Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03668223 · ClinicalTrials.gov registry record · NA
The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 195
- Enrollment target
NCT03668223 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 195 participants.
The verdict
NCT03668223, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 195 participants
- Enrollment target
Study Summary
Multi-Site Randomized Controlled Trial testing the efficacy of the Promoting Resilience in Stress Management (PRISM) intervention among Adolescents and Young Adults with Advanced Cancer
Interventions
- BEHAVIORAL Promoting Resilience in Stress Management (PRISM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2025-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03668223
The ClinicalTrials.gov registry entry for NCT03668223 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Promoting Resilience in Stress Management (PRISM) is the first listed.
NCT03668223 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03668223 about?
NCT03668223 is a clinical study titled "The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer". Multi-Site Randomized Controlled Trial testing the efficacy of the Promoting Resilience in Stress Management (PRISM) intervention among Adolescents and Young Adults with Advanced Cancer
What is the current status of trial NCT03668223?
This trial is currently completed. It is a NA study. The enrollment target is 195 participants. The study started on 2019-04-15. Estimated completion is 2025-10-31.
What interventions are being tested in trial NCT03668223?
The interventions under investigation include: Promoting Resilience in Stress Management (PRISM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03668223?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.